Breakdown | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 144.63M | 210.26M | 214.00M | 200.50M | 222.19M |
Gross Profit | 35.09M | 103.07M | 46.02M | 43.39M | 65.93M |
EBITDA | -4.92M | 3.10M | 7.29M | 2.57M | 19.61M |
Net Income | -15.99M | -5.06M | 333.00K | -5.37M | 6.06M |
Balance Sheet | |||||
Total Assets | 146.90M | 190.06M | 215.76M | 199.59M | 190.82M |
Cash, Cash Equivalents and Short-Term Investments | 24.77M | 7.03M | 13.14M | 7.35M | 7.15M |
Total Debt | 19.85M | 25.45M | 29.38M | 20.93M | 24.67M |
Total Liabilities | 57.26M | 80.61M | 94.95M | 84.96M | 100.59M |
Stockholders Equity | 89.64M | 109.45M | 120.81M | 114.62M | 90.23M |
Cash Flow | |||||
Free Cash Flow | 9.64M | 4.70M | 16.32M | 168.00K | 17.52M |
Operating Cash Flow | 12.34M | 6.55M | 18.57M | 2.69M | 19.33M |
Investing Cash Flow | 16.29M | -1.85M | -2.25M | -31.80M | -8.14M |
Financing Cash Flow | -10.90M | -10.91M | -10.59M | 29.42M | -14.51M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | AU$75.17M | 41.45 | 4.65% | ― | 5.51% | 244.64% | |
64 Neutral | AU$24.98M | 28.03 | 2.68% | 2.00% | 16.45% | 83.33% | |
62 Neutral | AU$3.02B | 29.09 | 4.95% | 4.87% | 2.19% | -27.19% | |
61 Neutral | €10.91M | ― | -11.13% | 109.38% | -77.84% | 72.40% | |
53 Neutral | AU$44.62M | ― | -14.68% | 8.87% | -44.48% | -419.84% | |
47 Neutral | AU$31.20M | ― | -38.51% | ― | -53.71% | 37.00% | |
30 Underperform | AU$3.15M | ― | ― | 252.94% | 81.95% |
McPherson’s Limited has reported expected revenue of $139 million for FY25, with four out of five core brands achieving revenue growth despite challenging conditions. The company has transitioned to a new operating model involving third-party warehousing and pharmacy wholesaler partnerships, which is expected to unlock EBIT benefits of $4 to $5 million annually. This strategic shift is aimed at supporting future growth and enhancing brand investment, positioning McPherson’s for improved operational performance in FY26.